Unanticipated Genetic Ramifications: Investigational Cancer Drug Raises Alarms with Extensive Mutagenic Activity
In study recently published in Nature Genetics, researchers from the prestigious University of Cambridge and Pennsylvania State University College of Medicine have unveiled disquieting revelations about the potential implications of an investigational cancer drug. The Culprit: CX-5461 and Its Development The drug in question, CX-5461, developed by Taiwanese pharmaceutical company Senhwa Biosciences under the […]